Nilda Mesa

Insider profile

Currently holds a position at United Therapeutics Corp

Performance

Overall performance
2.9

Performance over holding periods
2.9
30 days 90 days 120 days
Average return 1% 8.2% 15.1%
Success rate 40% 68% 82%
Transactions
11 0% Buy
34 71% Buy
47 69% Buy
Nilda Mesa's trades of United Therapeutics Corp's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Sale
Price
221.31
Quantity 85,500 +40.5%
Value US$3,465,438
Transaction date
Proposed sale
Price
211.10
Quantity 50,562
Value US$4,506,382
Transaction date
Sale
Price
309.04
Quantity 80,363 +32.5%
Value US$3,091,412
Transaction date
Proposed sale
Price
481.63
Quantity 187
Value US$90,065
Transaction date
Proposed sale
Price
289.99
Quantity 645
Value US$187,045
Transaction date
Sale
Price
355.77
Quantity 255 -4.4%
Value US$90,720
Transaction date
Proposed sale
Price
355.77
Quantity 255
Value US$90,720
Transaction date
Sale
Price
412.28
Quantity 224 -3.7%
Value US$92,350
Transaction date
Proposed sale
Price
412.28
Quantity 224
Value US$92,350
Transaction date
Sale
Price
318.58
Quantity 266 -5.0%
Value US$84,742
Transaction date
Proposed sale
Price
318.58
Quantity 266
Value US$84,742
Transaction date
Sale
Price
237.80
Quantity 325 -5.7%
Value US$77,285
Transaction date
Proposed sale
Price
237.80
Quantity 325
Value US$77,285
Transaction date
Sale
Price
244.90
Quantity 605 -9.6%
Value US$148,164
Transaction date
Proposed sale
Price
244.90
Quantity 605
Value US$148,165
Transaction date
Sale
Price
222.36
Quantity 383 -5.7%
Value US$85,164
Transaction date
Proposed sale
Price
222.36
Quantity 383
Value US$85,164
Transaction date
Sale
Price
214.81
Quantity 374 -6.1%
Value US$80,337
Transaction date
Proposed sale
Price
214.81
Quantity 374
Value US$80,337
Transaction date
Sale
Price
268.57
Quantity 290 -4.5%
Value US$77,886
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2026-05-13 2026-05-12 S Sale
85,500 +40.5%
221.31
US$3,465,438
85,500 +40.5% 221.31 US$3,465,438
2026-05-12 2026-05-12 PrS Proposed sale
50,562
211.10
US$4,506,382
50,562 211.10 US$4,506,382
2025-12-10 2025-12-09 S Sale
80,363 +32.5%
309.04
US$3,091,412
80,363 +32.5% 309.04 US$3,091,412
2025-12-09 2025-12-09 PrS Proposed sale
187
481.63
US$90,065
187 481.63 US$90,065
2025-06-25 2025-06-24 S Sale
645 -11.7%
289.99
US$187,045
645 -11.7% 289.99 US$187,045
2025-06-24 2025-06-24 PrS Proposed sale
645
289.99
US$187,045
645 289.99 US$187,045
2024-12-31 2024-12-30 S Sale
255 -4.4%
355.77
US$90,720
255 -4.4% 355.77 US$90,720
2024-12-30 2024-12-30 PrS Proposed sale
255
355.77
US$90,720
255 355.77 US$90,720
2024-11-12 2024-11-08 S Sale
224 -3.7%
412.28
US$92,350
224 -3.7% 412.28 US$92,350
2024-11-08 2024-11-08 PrS Proposed sale
224
412.28
US$92,350
224 412.28 US$92,350
2024-06-26 2024-06-25 S Sale
266 -5.0%
318.58
US$84,742
266 -5.0% 318.58 US$84,742
2024-06-25 2024-06-25 PrS Proposed sale
266
318.58
US$84,742
266 318.58 US$84,742
2024-03-29 2024-03-27 S Sale
325 -5.7%
237.80
US$77,285
325 -5.7% 237.80 US$77,285
2024-03-27 2024-03-27 PrS Proposed sale
325
237.80
US$77,285
325 237.80 US$77,285
2023-12-20 2023-12-19 S Sale
605 -9.6%
244.90
US$148,164
605 -9.6% 244.90 US$148,164
2023-12-19 2023-12-19 PrS Proposed sale
605
244.90
US$148,165
605 244.90 US$148,165
2023-09-15 2023-09-13 S Sale
383 -5.7%
222.36
US$85,164
383 -5.7% 222.36 US$85,164
2023-09-13 2023-09-13 PrS Proposed sale
383
222.36
US$85,164
383 222.36 US$85,164
2023-05-08 2023-05-05 S Sale
374 -6.1%
214.81
US$80,337
374 -6.1% 214.81 US$80,337
2023-05-05 2023-05-05 PrS Proposed sale
374
214.81
US$80,337
374 214.81 US$80,337
2022-11-07 2022-11-07 S Sale
290 -4.5%
268.57
US$77,886
290 -4.5% 268.57 US$77,886